Press Release

View all news

Incyte to Present at Upcoming Investor Conferences

May 23, 2023 at 8:00 AM EDT

WILMINGTON, Del.--(BUSINESS WIRE)--May 23, 2023-- Incyte (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of June:

  • William Blair 43rd Annual Growth Stock Conference on Tuesday, June 6, 2023 at 11:20 a.m. (CDT)
  • Goldman Sachs 44th Annual Global Healthcare Conference on Monday, June 12, 2023 at 8:40 a.m. (PDT)

The presentations will be webcast live and can be accessed at and will be available for replay for 30 days.

About Incyte

Incyte is a Wilmington, Delaware-based, global biopharmaceutical company focused on finding solutions for serious unmet medical needs through the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit and follow @Incyte.


Catalina Loveman
+1 302 498 6171

Gregory Shertzer
+1 302 274 4779

Source: Incyte